Sechenov School
Home › Pathology › Hemorrhagic Diathesis: Pathophysiology and Classification

Hemorrhagic Diathesis

Diathesis haemorrhagica

For medical students2 min readUpdated 2026-10-10

Hemorrhagic diatheses comprise a group of hemostatic system disorders characterized by coagulation abnormalities and increased bleeding tendencies. The pathology encompasses defects in the vascular wall, plasma clotting factors, and the platelet component.

Normal Platelet Count180–320 × 10⁹/L (or 180,000–350,000 per mm³)
Platelet Size2–5 µm diameter (microforms in Wiskott-Aldrich syndrome are <1.5 µm)
Coagulopathy CategoriesVascular, plasma, and platelet factors
Clinical FormsHemorrhagic disorders and thrombophilias

General Characteristics and Coagulopathies

Hemostatic disorders are divided into coagulopathies with bleeding (hemorrhagic syndrome) and thrombophilias, which feature an increased predisposition to thrombus formation. Pathogenetic factors are divided into vascular, plasma, and platelet components.

Coagulopathies with bleeding are subdivided into hereditary and acquired forms. Acquired forms frequently result from hepatocellular injury, anticoagulant therapy, vitamin C and K deficiencies, as well as high inhibitor activity or hyperfibrinolysis.

Angiopathies and Vasopathies

This group unites disorders caused by vascular wall lesions (predominantly affecting capillaries and pre-capillaries).

Differential diagnosis relies on bleeding time measurements, capillaroscopy, and functional tests (tourniquet test and pinch test).

Thrombocytopenias and Thrombocytopathies

Platelets (anucleated corpuscles, 2–5 µm in diameter) are formed in hematopoietic organs from megakaryocytes. Their pathologies are divided into quantitative changes and qualitative defects:

  1. Thrombocytopenias: Hereditary (caused by shortened platelet lifespan due to membrane or metabolic defects) and acquired (resulting from insufficient production, destruction, or intravascular thrombosis).
  2. Thrombocytopathies: Hereditary forms include Chediak-Higashi syndrome, von Willebrand disease, Bernard-Soulier syndrome, Wiskott-Aldrich syndrome, Fanconi anemia, and Glanzmann thrombasthenia. Acquired forms develop secondary to uremia, hematopoietic malignancies, liver cirrhosis, and disseminated intravascular coagulation (DIC).

Thrombophilias (Thrombotic Disease)

Conditions characterized by an increased tendency toward thrombosis.

Mnemonic

Platelets have a short lifespan, angiopathies target vessels, and coagulopathies are split between bleeding disorders and thrombophilias.

Frequently asked questions

What are the main components identified in the etiology of coagulopathies?

Three primary components are distinguished: vascular factors (impaired wall permeability), plasma factors, and platelet factors.

What is the difference between hemorrhagic disorders and thrombophilias?

Hemorrhagic disorders are coagulopathies accompanied by increased bleeding. Thrombophilias (thrombotic disease) are coagulopathies characterized by an increased propensity for thrombus formation.

What are the mechanisms underlying acquired thrombocytopenias?

Three main mechanisms exist: inadequate bone marrow production, accelerated destruction or consumption within the vascular bed, and intravascular thrombosis.

Go deeper

More topics in Pathology

Secondary CardiomyopathiesDiabetic NephropathyChronic BronchitisGastric CancerAlcoholic Liver DiseaseParainfluenza and Related Tropical and Prion InfectionsTumor Metastasis: Pathophysiology and MechanismsSalivary Gland TumorsStromal-Vascular Protein DystrophiesAcute UlcersHIV Infection: Pathogenesis, Stages and PathologySystemic SclerosisPathology →